We are live on !
Find out more
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter Est. Return
+29.97%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.46B
AUM Growth
+$496M
(+25%)
Cap. Flow
+$126M
Cap. Flow % of AUM
Cap. Flow %
5.12%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
188
New
26
Increased
91
Reduced
27
Closed
22
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$52.1M |
| 2 |
DexCom
DXCM
|
+$46.7M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$8.53M |
| 4 |
Parker-Hannifin
PH
|
+$5.29M |
| 5 |
Broadcom
AVGO
|
+$5.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$24.9M |
| 2 |
KLA
KLAC
|
+$21.4M |
| 3 |
Workday
WDAY
|
+$21M |
| 4 |
Comfort Systems
FIX
|
+$14.1M |
| 5 |
TSMC
TSM
|
+$8.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.09% |
| 2 | Financials | 11.79% |
| 3 | Communication Services | 11.58% |
| 4 | Industrials | 11.01% |
| 5 | Healthcare | 10.91% |
Similar funds
Smith Group Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Smith Group Asset Management held 188 positions worth $2.46B, up 25% from $1.96B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Smith Group Asset Management deployed $126M of net new capital in Q2 2026, opening 26 new positions and adding to 91 existing holdings. Its largest new stake was DexCom: 701,347 shares worth $47.2M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was KLA, an estimated $21.4M trimmed.
- Smith Group Asset Management's largest Q2 2026 buy was DexCom: 701,347 shares worth $47.2M.
- Smith Group Asset Management added most to Lam Research in Q2 2026, an estimated $52.1M increase.
- Smith Group Asset Management's biggest Q2 2026 reduction was KLA, cutting an estimated $21.4M.
- Smith Group Asset Management fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $24.9M.
- Smith Group Asset Management's ten largest holdings make up 38% of its $2.46B portfolio in Q2 2026.
- Smith Group Asset Management opened 26 new positions and closed 22 in Q2 2026.
- Smith Group Asset Management's portfolio value rose 25% quarter-over-quarter to $2.46B.
Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.